Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction

Abstract Despite striking advances in the treatment of metastasized melanoma, the disease is often still fatal. Attention is therefore paid towards combinational regimens. Oxidants endogenously produced in mitochondria are currently targeted in pre-clinical and clinical studies. Cytotoxic synergism...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rajesh Kumar Gandhirajan, Katrin Rödder, Yana Bodnar, Gabriella Pasqual-Melo, Steffen Emmert, Corinne E. Griguer, Klaus-Dieter Weltmann, Sander Bekeschus
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e7765252a4bf4fd98c1c2fb12bede776
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e7765252a4bf4fd98c1c2fb12bede776
record_format dspace
spelling oai:doaj.org-article:e7765252a4bf4fd98c1c2fb12bede7762021-12-02T15:08:44ZCytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction10.1038/s41598-018-31031-22045-2322https://doaj.org/article/e7765252a4bf4fd98c1c2fb12bede7762018-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-31031-2https://doaj.org/toc/2045-2322Abstract Despite striking advances in the treatment of metastasized melanoma, the disease is often still fatal. Attention is therefore paid towards combinational regimens. Oxidants endogenously produced in mitochondria are currently targeted in pre-clinical and clinical studies. Cytotoxic synergism of mitochondrial cytochrome c oxidase (CcO) inhibition in conjunction with addition of exogenous oxidants in 2D and 3D melanoma cell culture models were examined. Murine (B16) and human SK-MEL-28 melanoma cells exposed to low-dose CcO inhibitors (potassium cyanide or sodium azide) or exogenous oxidants alone were non-toxic. However, we identified a potent cytotoxic synergism upon CcO inhibition and plasma-derived oxidants that led to rapid onset of caspase-independent melanoma cell death. This was mediated by mitochondrial dysfunction induced by superoxide elevation and ATP depletion. This observation was validated by siRNA-mediated knockdown of COX4I1 in SK-MEL-28 cells with cytotoxicity in the presence of exogenous oxidants. Similar effects were obtained with ADDA 5, a recently identified specific inhibitor of CcO activity showing low toxicity in vivo. Human keratinocytes were not affected by this combinational treatment, suggesting selective effects on melanoma cells. Hence, targeting mitochondrial CcO activity in conjunction with exogenous pro oxidant therapies may constitute a new and effective melanoma treatment modality.Rajesh Kumar GandhirajanKatrin RödderYana BodnarGabriella Pasqual-MeloSteffen EmmertCorinne E. GriguerKlaus-Dieter WeltmannSander BekeschusNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rajesh Kumar Gandhirajan
Katrin Rödder
Yana Bodnar
Gabriella Pasqual-Melo
Steffen Emmert
Corinne E. Griguer
Klaus-Dieter Weltmann
Sander Bekeschus
Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction
description Abstract Despite striking advances in the treatment of metastasized melanoma, the disease is often still fatal. Attention is therefore paid towards combinational regimens. Oxidants endogenously produced in mitochondria are currently targeted in pre-clinical and clinical studies. Cytotoxic synergism of mitochondrial cytochrome c oxidase (CcO) inhibition in conjunction with addition of exogenous oxidants in 2D and 3D melanoma cell culture models were examined. Murine (B16) and human SK-MEL-28 melanoma cells exposed to low-dose CcO inhibitors (potassium cyanide or sodium azide) or exogenous oxidants alone were non-toxic. However, we identified a potent cytotoxic synergism upon CcO inhibition and plasma-derived oxidants that led to rapid onset of caspase-independent melanoma cell death. This was mediated by mitochondrial dysfunction induced by superoxide elevation and ATP depletion. This observation was validated by siRNA-mediated knockdown of COX4I1 in SK-MEL-28 cells with cytotoxicity in the presence of exogenous oxidants. Similar effects were obtained with ADDA 5, a recently identified specific inhibitor of CcO activity showing low toxicity in vivo. Human keratinocytes were not affected by this combinational treatment, suggesting selective effects on melanoma cells. Hence, targeting mitochondrial CcO activity in conjunction with exogenous pro oxidant therapies may constitute a new and effective melanoma treatment modality.
format article
author Rajesh Kumar Gandhirajan
Katrin Rödder
Yana Bodnar
Gabriella Pasqual-Melo
Steffen Emmert
Corinne E. Griguer
Klaus-Dieter Weltmann
Sander Bekeschus
author_facet Rajesh Kumar Gandhirajan
Katrin Rödder
Yana Bodnar
Gabriella Pasqual-Melo
Steffen Emmert
Corinne E. Griguer
Klaus-Dieter Weltmann
Sander Bekeschus
author_sort Rajesh Kumar Gandhirajan
title Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction
title_short Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction
title_full Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction
title_fullStr Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction
title_full_unstemmed Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction
title_sort cytochrome c oxidase inhibition and cold plasma-derived oxidants synergize in melanoma cell death induction
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/e7765252a4bf4fd98c1c2fb12bede776
work_keys_str_mv AT rajeshkumargandhirajan cytochromecoxidaseinhibitionandcoldplasmaderivedoxidantssynergizeinmelanomacelldeathinduction
AT katrinrodder cytochromecoxidaseinhibitionandcoldplasmaderivedoxidantssynergizeinmelanomacelldeathinduction
AT yanabodnar cytochromecoxidaseinhibitionandcoldplasmaderivedoxidantssynergizeinmelanomacelldeathinduction
AT gabriellapasqualmelo cytochromecoxidaseinhibitionandcoldplasmaderivedoxidantssynergizeinmelanomacelldeathinduction
AT steffenemmert cytochromecoxidaseinhibitionandcoldplasmaderivedoxidantssynergizeinmelanomacelldeathinduction
AT corinneegriguer cytochromecoxidaseinhibitionandcoldplasmaderivedoxidantssynergizeinmelanomacelldeathinduction
AT klausdieterweltmann cytochromecoxidaseinhibitionandcoldplasmaderivedoxidantssynergizeinmelanomacelldeathinduction
AT sanderbekeschus cytochromecoxidaseinhibitionandcoldplasmaderivedoxidantssynergizeinmelanomacelldeathinduction
_version_ 1718388033596686336